What Are the Effects and Benefits of Sodium Hyaluronate Injections?

Sodium hyaluronate injections are a well-established therapeutic intervention primarily used to manage osteoarthritis—particularly in weight-bearing joints such as the knee. As a naturally occurring glycosaminoglycan and a key component of synovial fluid, sodium hyaluronate contributes significantly to joint lubrication, shock absorption, and cartilage nutrition. In osteoarthritis, endogenous hyaluronic acid concentration and molecular weight decline, resulting in diminished viscoelasticity of synovial fluid and impaired joint homeostasis.

Clinically, intra-articular sodium hyaluronate injections aim to restore physiological joint function by supplementing depleted hyaluronan. This restoration enhances viscosity and elasticity of synovial fluid, reduces mechanical stress on articular cartilage, and exerts anti-inflammatory and chondroprotective effects—modulating cytokine expression, inhibiting metalloproteinase activity, and supporting synoviocyte health. Evidence from randomized controlled trials and meta-analyses supports its efficacy in reducing pain, improving functional mobility (e.g., walking distance and stair climbing), and delaying progression toward surgical intervention in patients with mild-to-moderate knee osteoarthritis.

While generally well tolerated, potential adverse reactions include transient injection-site pain, swelling, warmth, or stiffness—typically resolving within 48–72 hours. Rare but notable complications include acute pseudoseptic arthritis (a sterile inflammatory response) and hypersensitivity reactions. Contraindications include active joint infection, overlying skin infection at the injection site, and severe coagulopathy. Treatment protocols vary by formulation; most regimens involve weekly injections for three to five weeks, with symptom relief often emerging after the second or third dose and lasting up to six months.

It is important to emphasize that sodium hyaluronate therapy is not a disease-modifying agent in the strictest sense—it does not reverse structural cartilage loss—but rather serves as a symptomatic, structure-sparing adjunct within a comprehensive management strategy that includes weight optimization, physical therapy, and pharmacologic pain control.